Multicomponent Agents for Prevention and Treatment of Digestive Diseases
Introduction. In recent years, there has been a steady increase in gastroenterological diseases in many countries due to adverse environmental conditions and unsustainable nutrition. Diseases of digestive organs are not only chronic, but also combined, and varieties of synthetic drugs are widely use...
Main Author: | E. V. Ferubko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2020-08-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/819 |
Similar Items
-
CHARACTERISTICS OF LIPID STORAGE DISORDERS IN CHILDREN WITH HEPATOBILIARY PATHOLOGY
by: А. E. Lavrova, et al.
Published: (2014-03-01) -
Desferal-Induced Inhibition of Lipid Peroxidation Processes in Experimental Pancreatic Necrosis
by: Yu. P. Orlov, et al.
Published: (2007-08-01) -
INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS
by: A. A. Usanova, et al.
Published: (2016-01-01) -
Comparative assessment of hepatoprotective effects of various liposome formulations in experimental venous congestion-induced chronic liver insufficiency
by: R. A. Mukhamadiyarov, et al.
Published: (2012-08-01) -
Copaxone in therapy of remittent disseminated sclerosis patients
by: O. A. Kitcherova, et al.
Published: (2008-09-01)